×
Home
Current Archive Editorial Board News Contact
Research paper

CORONARY ATHEROSCLEROSIS ASSESSMENT: A NEW ANATOMICAL, FUNCTIONAL, MORPHOLOGICAL AND BIO-MECHANICAL APPROACH

By
Panagiotis K. Siogkas ,
Panagiotis K. Siogkas
Georgios-Eleftherios Kalykakis ,
Georgios-Eleftherios Kalykakis
Constantinos D. Anagnostopoulos ,
Constantinos D. Anagnostopoulos
Themis P. Exarchos
Themis P. Exarchos

Abstract

The aims of this work are to investigate and compare two different flow dynamics techniques (steady state - pulsatile flow) for endothelial shear stress calculation, compare lesion specific smartFFR and ESS values, as well as total vessel smartFFR and ESS values, and investigate the relationship between smartFFR and ESS to stress MBF (myocardial blood flow) and MFR (myocardial flow reserve). A total of 10 coronary vessels of 6 patients with intermediate pre-test likelihood for coronary artery disease, who have undergone both CTCA and PET-MPI with 15O-water or 13N-ammonia, were included in the study. Seven (7) cases had normal stress MBF and MFR values and three (3) had abnormal ones. PET was considered abnormal when > 1 contiguous segments showed both stress MBF ≤2.3mL/g/min and MFR ≤2.5 for 15O-water or 1.79 mL/g/min and ≤2.0 for 13N-ammonia, respectively. The ESS at the luminal surface of the artery was calculated as the product of viscosity and the gradient of blood velocity near the vessel wall. To calculate the smartFFR, we performed a transient simulation for each case. We used a pressure of 100 mmHg as a boundary condition at the inlet (i.e. mean human aortic pressure). At the outlet, a flow profile of 4 timesteps with a timestep duration of 0.25 sec was used. In each timestep, a volumetric flow rate of 1, 2, 3 and 4 ml/s are applied as outlet boundary conditions. The cut-off value for a pathological smartFFR is 0.83. There is a difference in total vessel calculated smartFFR results compared to the corresponding values of lesion specific smartFFR (0.88 vs 0.97, p=0.01). For ESS there is a negligible difference between lesion specific and total vessel values (2.22 vs 2.74, p = 0.9). There is a moderate negative correlation between both lesions specific (r = -0.543) and total vessel smartFFR and ESS (r = -0.915). ESS values were higher in vessels where vessel smartFFR was considered abnormal (1.97 vs 5.52, p = 0.01). Total vessel length smartFFR was lower in vessels with abnormal PET-MPI compared to the normal vessels (0.75 vs 0.93, p = 0.01). ESS is higher in vessels with pathological stress MBF and CFR (5.5 vs 2.0, p = 0.02). The total vessel length smartFFR and lesion ESS appear to assess the functional significance of the vessel well, when compared to the PET-MPI measurements.

References

1.
Athanasiou L, Rigas G, Sakellarios AI, Exarchos TP, Siogkas PK, Bourantas CV, et al. Three-dimensional reconstruction of coronary arteries and plaque morphology using CT angiography – comparison and registration with IVUS. BMC Medical Imaging. 2016;16(1).
2.
Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, et al. Quantitative Assessment of Myocardial Perfusion in the Detection of Significant Coronary Artery Disease. Journal of the American College of Cardiology. 2014;64(14):1464–75.
3.
De Bruyne B, Fearon WF, Pijls NHJ, Barbato E, Tonino P, Piroth Z, et al. Fractional Flow Reserve–Guided PCI for Stable Coronary Artery Disease. New England Journal of Medicine. 2014;371(13):1208–17.
4.
R. EN, M. TJ, M. CM, A. WE, F RJH. PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology. *Curr Atheroscler Rep*. 2016;18(6).
5.
Pantos I, Katritsis D. Fractional Flow Reserve Derived from Coronary Imaging and Computational Fluid Dynamics. Interventional Cardiology Review. 2014;9(3):145.
6.
Li L, Li X, Jia Y, Fan J, Wang H, Fan C, et al. Sodium-fluoride PET-CT for the non-invasive evaluation of coronary plaques in symptomatic patients with coronary artery disease: a cross-correlation study with intravascular ultrasound. European Journal of Nuclear Medicine and Molecular Imaging. 2018;45(12):2181–9.
7.
Neglia D, Rovai D, Caselli C, Pietila M, Teresinska A, Aguadé-Bruix S, et al. Detection of Significant Coronary Artery Disease by Noninvasive Anatomical and Functional Imaging. Circulation: Cardiovascular Imaging. 2015;8(3).
8.
I. SA. SMARTool: A tool for clinical decision support for the management of patients with coronary artery disease based on modeling of atherosclerotic plaque process. In: *Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBS)*. 2017. p. 96–9.
9.
Siogkas PK, Lakkas L, Sakellarios AI, Rigas G, Kyriakidis S, Stefanou KA, et al. SmartFFR, a New Functional Index of Coronary Stenosis: Comparison With Invasive FFR Data. Frontiers in Cardiovascular Medicine. 8.
10.
Tang CX, Liu CY, Lu MJ, Schoepf UJ, Tesche C, Bayer RR, et al. CT FFR for Ischemia-Specific CAD With a New Computational Fluid Dynamics Algorithm. JACC: Cardiovascular Imaging. 2020;13(4):980–90.
11.
Tesche C, De Cecco CN, Albrecht MH, Duguay TM, Bayer RR, Litwin SE, et al. Coronary CT Angiography–derived Fractional Flow Reserve. Radiology. 2017;285(1):17–33.
12.
W.H.O. Cardiovascular diseases. 2019;

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.